Browse the articles below for answers to common questions before booking your appointment
In animals, GSH synthesis is regulated by feedback inhibition based on cysteine availability and the balance between the catalytic and regulatory subunits of glutamate-cysteine ligase (GCL) (Yang et al., 2002)
Description for Soliqua Injection SOLIQUA 100/33 (insulin glargine and lixisenatide injection), for subcutaneous use, is a combination of a long-acting basal insulin analog, insulin glargine, and a GLP-1 receptor agonist, lixisenatide
A recent study demonstrated their potential benefit in patients with mast cell activation syndrome (MCAS) [21]
TL: is an employee of Novo Nordisk A/S
In the SURMOUNT trials, up to 5% of users reported hair loss